111 related articles for article (PubMed ID: 3827987)
1. Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic non-insulin-dependent diabetics.
Kasama T; Yoshino G; Iwatani I; Iwai M; Hatanaka H; Kazumi T; Oimomi M; Baba S
Atherosclerosis; 1987 Feb; 63(2-3):263-6. PubMed ID: 3827987
[TBL] [Abstract][Full Text] [Related]
2. Influence of early diabetic nephropathy on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition.
Winocour PH; Durrington PN; Bhatnagar D; Ishola M; Mackness M; Arrol S
Atherosclerosis; 1991 Jul; 89(1):49-57. PubMed ID: 1772471
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
4. Intermediate density lipoprotein levels are strong predictors of the extent of aortic atherosclerosis in the St. Thomas's Hospital rabbit strain.
Nordestgaard BG; Lewis B
Atherosclerosis; 1991 Mar; 87(1):39-46. PubMed ID: 1872923
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of VLDL, IDL, and LDL characterize insulin-dependent diabetes mellitus.
Winocour PH; Durrington PN; Bhatnagar D; Ishola M; Arrol S; Mackness M
Arterioscler Thromb; 1992 Aug; 12(8):920-8. PubMed ID: 1637789
[TBL] [Abstract][Full Text] [Related]
6. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
7. Plasma lipoprotein changes during abstinence in chronic alcoholics.
Weidman SW; Beard JD; Sabesin SM
Atherosclerosis; 1984 Aug; 52(2):151-66. PubMed ID: 6433939
[TBL] [Abstract][Full Text] [Related]
8. The effect of bezafibrate on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition in type 1 diabetes associated with hypercholesterolaemia or combined hyperlipidaemia.
Winocour PH; Durrington PN; Bhatagnar D; Ishola M; Mackness M; Arrol S; Anderson DC
Atherosclerosis; 1992 Mar; 93(1-2):83-94. PubMed ID: 1596307
[TBL] [Abstract][Full Text] [Related]
9. Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease.
Syvänne M; Hilden H; Taskinen MR
J Lipid Res; 1994 Jan; 35(1):15-26. PubMed ID: 8138716
[TBL] [Abstract][Full Text] [Related]
10. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
[TBL] [Abstract][Full Text] [Related]
11. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.
Tatami R; Mabuchi H; Ueda K; Ueda R; Haba T; Kametani T; Ito S; Koizumi J; Ohta M; Miyamoto S; Nakayama A; Kanaya H; Oiwake H; Genda A; Takeda R
Circulation; 1981 Dec; 64(6):1174-84. PubMed ID: 7296792
[TBL] [Abstract][Full Text] [Related]
12. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
[TBL] [Abstract][Full Text] [Related]
13. Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM.
Abate N; Vega GL; Garg A; Grundy SM
Atherosclerosis; 1995 Nov; 118(1):111-22. PubMed ID: 8579621
[TBL] [Abstract][Full Text] [Related]
14. A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals.
Balling M; Langsted A; Afzal S; Varbo A; Davey Smith G; Nordestgaard BG
Atherosclerosis; 2019 Jul; 286():97-104. PubMed ID: 31108411
[TBL] [Abstract][Full Text] [Related]
15. Type 1 (insulin-dependent) versus type 2 (non-insulin-dependent) diabetes mellitus: characterization of serum lipoprotein alterations.
Weisweiler P; Schwandt P
Eur J Clin Invest; 1987 Feb; 17(1):87-91. PubMed ID: 3106055
[TBL] [Abstract][Full Text] [Related]
16. Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: cholesterol acyltransferase activity in diabetes mellitus.
Schernthaner G; Kostner GM; Dieplinger H; Prager R; Mühlhauser I
Atherosclerosis; 1983 Dec; 49(3):277-93. PubMed ID: 6229255
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein compositional abnormalities in type I diabetes: effect of improved glycaemic control.
Pérez A; Caixàs A; Carreras G; Mauricio D; Pou JM; Serrat J; Gómez-Gerique J; de Leiva A
Diabetes Res Clin Pract; 1997 May; 36(2):83-90. PubMed ID: 9229192
[TBL] [Abstract][Full Text] [Related]
18. Effect of dietary treatment on the lipid, lipoprotein and fatty acid compositions in type IV familial hypertriglyceridemia.
Agheli N; Cloarec M; Jacotot B
Ann Nutr Metab; 1991; 35(5):261-73. PubMed ID: 1776822
[TBL] [Abstract][Full Text] [Related]
19. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.
Shoji T; Nishizawa Y; Kawagishi T; Tanaka M; Kawasaki K; Tabata T; Inoue T; Morii H
Atherosclerosis; 1997 Jun; 131(2):229-36. PubMed ID: 9199276
[TBL] [Abstract][Full Text] [Related]
20. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness.
Hodis HN; Mack WJ; Dunn M; Liu C; Liu C; Selzer RH; Krauss RM
Circulation; 1997 Apr; 95(8):2022-6. PubMed ID: 9133510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
